# AN2 Therapeutics, Inc.: Form SCHEDULE 13D, filed May 7, 2025

- Company: [AN2 Therapeutics, Inc.](/companies/antx.md) (CIK 1880438)
- Form: SCHEDULE 13D
- Filed: 2025-05-07
- Accepted by EDGAR: May 7, 2025, 10:27 ET
- Period: not reported
- Accession: 0001373604-25-000074
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1880438/000137360425000074/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1880438/000137360425000074/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1880438/000137360425000074/xslSCHEDULE_13D_X01/primary_doc.xml

Filed May 7, 2025.
Source: SEC EDGAR, the filing index for accession 0001373604-25-000074. Last ingested by Listed: Nov 6, 2026, 18:51 ET. No prices; not investment advice.